$200 Million is the total value of OIKOS HOLDINGS LLC's 11 reported holdings in Q4 2022. The portfolio turnover from Q3 2022 to Q4 2022 was 57.1% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
VXF | New | VANGUARD INDEX FDSextend mkt etf | $64,981,826 | – | 489,100 | +100.0% | 32.55% | – |
VOO | Sell | VANGUARD INDEX FDS | $34,965,708 | -20.3% | 99,521 | -25.5% | 17.52% | +8.9% |
IWM | New | ISHARES TRrussell 2000 etf | $23,416,548 | – | 134,300 | +100.0% | 11.73% | – |
USRT | New | ISHARES TRcre u s reit etf | $17,332,225 | – | 350,500 | +100.0% | 8.68% | – |
VTI | Sell | VANGUARD INDEX FDStotal stk mkt | $12,608,981 | -82.9% | 65,950 | -84.0% | 6.32% | -76.6% |
VXUS | Sell | VANGUARD STAR FDSvg tl intl stk f | $12,371,631 | -84.7% | 239,204 | -86.5% | 6.20% | -79.1% |
ITOT | Sell | ISHARES TRcore s&p ttl stk | $9,248,797 | -71.1% | 109,066 | -72.9% | 4.63% | -60.4% |
SCHF | New | SCHWAB STRATEGIC TRintl eqty etf | $7,591,897 | – | 235,700 | +100.0% | 3.80% | – |
VCSH | Sell | VANGUARD SCOTTSDALE FDSshrt trm corp bd | $6,954,699 | -22.6% | 92,495 | -23.5% | 3.48% | +5.9% |
VNQ | Sell | VANGUARD INDEX FDSreal estate etf | $6,753,545 | -70.9% | 81,881 | -71.7% | 3.38% | -60.2% |
VEU | Sell | VANGUARD INTL EQUITY INDEX Fallwrld ex us | $3,410,072 | -66.5% | 68,011 | -70.4% | 1.71% | -54.2% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-01-26
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
VANGUARD INDEX FDS | 13 | Q3 2023 | 82.8% |
VANGUARD INDEX FDS | 11 | Q3 2023 | 42.2% |
VANGUARD STAR FDS | 10 | Q3 2023 | 32.6% |
VANGUARD SCOTTSDALE FDS | 9 | Q3 2023 | 7.4% |
ISHARES TR | 8 | Q3 2019 | 62.5% |
FGL HLDGS | 8 | Q3 2019 | 39.0% |
ISHARES TR | 8 | Q3 2023 | 16.0% |
VANGUARD INTL EQUITY INDEX F | 8 | Q3 2023 | 4.0% |
VANGUARD INDEX FDS | 7 | Q3 2023 | 13.7% |
MELINTA THERAPEUTICS INC | 5 | Q4 2018 | 64.1% |
View OIKOS HOLDINGS LLC's complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
MELINTA THERAPEUTICS, INC. /NEW/ | December 20, 2018 | 16,007,237 | 28.6% |
View OIKOS HOLDINGS LLC's complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-02-02 |
13F-HR | 2023-11-01 |
13F-HR | 2023-08-14 |
13F-HR | 2023-04-27 |
13F-HR | 2023-01-26 |
13F-HR | 2022-11-02 |
13F-HR | 2022-07-28 |
13F-HR | 2022-04-28 |
13F-HR | 2022-01-31 |
13F-HR | 2021-10-19 |
View OIKOS HOLDINGS LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.